Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

PH vs EMR

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
PH
Parker-Hannifin Corporation

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$113.93B
5Y Perf.+401.6%
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$83.18B
5Y Perf.+142.4%

PH vs EMR — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
PH logoPH
EMR logoEMR
IndustryIndustrial - MachineryIndustrial - Machinery
Market Cap$113.93B$83.18B
Revenue (TTM)$20.99B$18.32B
Net Income (TTM)$3.48B$2.44B
Gross Margin37.2%39.4%
Operating Margin20.9%19.4%
Forward P/E29.1x22.8x
Total Debt$9.64B$13.76B
Cash & Equiv.$467M$1.54B

PH vs EMRLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

PH
EMR
StockMay 20May 26Return
Parker-Hannifin Cor… (PH)100501.6+401.6%
Emerson Electric Co. (EMR)100242.4+142.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: PH vs EMR

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: PH leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Emerson Electric Co. is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
PH
Parker-Hannifin Corporation
The Long-Run Compounder

PH carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.

  • 7.4% 10Y total return vs EMR's 215.5%
  • Lower volatility, beta 1.00, Low D/E 70.4%, current ratio 1.19x
  • PEG 1.22 vs EMR's 5.04
Best for: long-term compounding and sleep-well-at-night
EMR
Emerson Electric Co.
The Income Pick

EMR is the clearest fit if your priority is income & stability and growth exposure.

  • Dividend streak 37 yrs, beta 1.52, yield 1.4%
  • Rev growth 3.0%, EPS growth 17.8%, 3Y rev CAGR 9.3%
  • 3.0% revenue growth vs PH's -0.4%
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthEMR logoEMR3.0% revenue growth vs PH's -0.4%
ValueEMR logoEMRLower P/E (22.8x vs 29.1x)
Quality / MarginsPH logoPH16.6% margin vs EMR's 13.3%
Stability / SafetyPH logoPHBeta 1.00 vs EMR's 1.52
DividendsEMR logoEMR1.4% yield, 37-year raise streak, vs PH's 0.7%
Momentum (1Y)PH logoPH+48.2% vs EMR's +39.9%
Efficiency (ROA)PH logoPH11.5% ROA vs EMR's 5.8%, ROIC 13.4% vs 8.2%

PH vs EMR — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

PHParker-Hannifin Corporation
FY 2025
Diversified Industrial Segment
68.8%$13.7B
Aerospace Systems Segment
31.2%$6.2B
EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B

PH vs EMR — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLPHLAGGINGEMR

Income & Cash Flow (Last 12 Months)

PH leads this category, winning 4 of 6 comparable metrics.

PH and EMR operate at a comparable scale, with $21.0B and $18.3B in trailing revenue. Profitability is closely matched — net margins range from 16.6% (PH) to 13.3% (EMR). On growth, PH holds the edge at +10.6% YoY revenue growth, suggesting stronger near-term business momentum.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
RevenueTrailing 12 months$21.0B$18.3B
EBITDAEarnings before interest/tax$5.1B$4.7B
Net IncomeAfter-tax profit$3.5B$2.4B
Free Cash FlowCash after capex$3.7B$3.1B
Gross MarginGross profit ÷ Revenue+37.2%+39.4%
Operating MarginEBIT ÷ Revenue+20.9%+19.4%
Net MarginNet income ÷ Revenue+16.6%+13.3%
FCF MarginFCF ÷ Revenue+17.5%+17.0%
Rev. Growth (YoY)Latest quarter vs prior year+10.6%+2.9%
EPS Growth (YoY)Latest quarter vs prior year-4.2%+28.2%
PH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

EMR leads this category, winning 5 of 7 comparable metrics.

At 33.3x trailing earnings, PH trades at a 9% valuation discount to EMR's 36.6x P/E. Adjusting for growth (PEG ratio), PH offers better value at 1.39x vs EMR's 8.11x — a lower PEG means you pay less per unit of expected earnings growth.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
Market CapShares × price$113.9B$83.2B
Enterprise ValueMkt cap + debt − cash$123.1B$95.4B
Trailing P/EPrice ÷ TTM EPS33.28x36.61x
Forward P/EPrice ÷ next-FY EPS est.29.11x22.77x
PEG RatioP/E ÷ EPS growth rate1.39x8.11x
EV / EBITDAEnterprise value multiple24.78x18.89x
Price / SalesMarket cap ÷ Revenue5.74x4.62x
Price / BookPrice ÷ Book value/share8.58x4.13x
Price / FCFMarket cap ÷ FCF34.10x31.19x
EMR leads this category, winning 5 of 7 comparable metrics.

Profitability & Efficiency

PH leads this category, winning 8 of 9 comparable metrics.

PH delivers a 24.3% return on equity — every $100 of shareholder capital generates $24 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to PH's 0.70x. On the Piotroski fundamental quality scale (0–9), PH scores 8/9 vs EMR's 7/9, reflecting strong financial health.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
ROE (TTM)Return on equity+24.3%+12.1%
ROA (TTM)Return on assets+11.5%+5.8%
ROICReturn on invested capital+13.4%+8.2%
ROCEReturn on capital employed+17.8%+10.0%
Piotroski ScoreFundamental quality 0–987
Debt / EquityFinancial leverage0.70x0.68x
Net DebtTotal debt minus cash$9.2B$12.2B
Cash & Equiv.Liquid assets$467M$1.5B
Total DebtShort + long-term debt$9.6B$13.8B
Interest CoverageEBIT ÷ Interest expense11.39x6.61x
PH leads this category, winning 8 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

PH leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in PH five years ago would be worth $29,479 today (with dividends reinvested), compared to $16,900 for EMR. Over the past 12 months, PH leads with a +48.2% total return vs EMR's +39.9%. The 3-year compound annual growth rate (CAGR) favors PH at 40.2% vs EMR's 22.6% — a key indicator of consistent wealth creation.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
YTD ReturnYear-to-date+1.2%+9.3%
1-Year ReturnPast 12 months+48.2%+39.9%
3-Year ReturnCumulative with dividends+175.4%+84.1%
5-Year ReturnCumulative with dividends+194.8%+69.0%
10-Year ReturnCumulative with dividends+741.1%+215.5%
CAGR (3Y)Annualised 3-year return+40.2%+22.6%
PH leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — PH and EMR each lead in 1 of 2 comparable metrics.

PH is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
Beta (5Y)Sensitivity to S&P 5001.00x1.52x
52-Week HighHighest price in past year$1034.96$165.15
52-Week LowLowest price in past year$608.31$106.53
% of 52W HighCurrent price vs 52-week peak+87.2%+89.6%
RSI (14)Momentum oscillator 0–10033.948.4
Avg Volume (50D)Average daily shares traded710K2.8M
Evenly matched — PH and EMR each lead in 1 of 2 comparable metrics.

Analyst Outlook

EMR leads this category, winning 2 of 2 comparable metrics.

Wall Street rates PH as "Buy" and EMR as "Buy". Consensus price targets imply 15.4% upside for PH (target: $1042) vs 9.5% for EMR (target: $162). For income investors, EMR offers the higher dividend yield at 1.42% vs PH's 0.73%.

MetricPH logoPHParker-Hannifin C…EMR logoEMREmerson Electric …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$1042.08$161.92
# AnalystsCovering analysts3841
Dividend YieldAnnual dividend ÷ price+0.7%+1.4%
Dividend StreakConsecutive years of raises3337
Dividend / ShareAnnual DPS$6.61$2.10
Buyback YieldShare repurchases ÷ mkt cap+1.5%+1.5%
EMR leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

PH leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). EMR leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallParker-Hannifin Corporation (PH)Leads 3 of 6 categories
Loading custom metrics...

PH vs EMR: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is PH or EMR a better buy right now?

For growth investors, Emerson Electric Co.

(EMR) is the stronger pick with 3. 0% revenue growth year-over-year, versus -0. 4% for Parker-Hannifin Corporation (PH). Parker-Hannifin Corporation (PH) offers the better valuation at 33. 3x trailing P/E (29. 1x forward), making it the more compelling value choice. Analysts rate Parker-Hannifin Corporation (PH) a "Buy" — based on 38 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — PH or EMR?

On trailing P/E, Parker-Hannifin Corporation (PH) is the cheapest at 33.

3x versus Emerson Electric Co. at 36. 6x. On forward P/E, Emerson Electric Co. is actually cheaper at 22. 8x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Parker-Hannifin Corporation wins at 1. 22x versus Emerson Electric Co. 's 5. 04x — a reasonable growth-adjusted valuation.

03

Which is the better long-term investment — PH or EMR?

Over the past 5 years, Parker-Hannifin Corporation (PH) delivered a total return of +194.

8%, compared to +69. 0% for Emerson Electric Co. (EMR). Over 10 years, the gap is even starker: PH returned +741. 1% versus EMR's +215. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — PH or EMR?

By beta (market sensitivity over 5 years), Parker-Hannifin Corporation (PH) is the lower-risk stock at 1.

00β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 53% more volatile than PH relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 70% for Parker-Hannifin Corporation — giving it more financial flexibility in a downturn.

05

Which is growing faster — PH or EMR?

By revenue growth (latest reported year), Emerson Electric Co.

(EMR) is pulling ahead at 3. 0% versus -0. 4% for Parker-Hannifin Corporation (PH). On earnings-per-share growth, the picture is similar: Parker-Hannifin Corporation grew EPS 24. 2% year-over-year, compared to 17. 8% for Emerson Electric Co.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — PH or EMR?

Parker-Hannifin Corporation (PH) is the more profitable company, earning 17.

8% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PH leads at 20. 5% versus 19. 6% for EMR. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is PH or EMR more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Parker-Hannifin Corporation (PH) is the more undervalued stock at a PEG of 1. 22x versus Emerson Electric Co. 's 5. 04x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Emerson Electric Co. (EMR) trades at 22. 8x forward P/E versus 29. 1x for Parker-Hannifin Corporation — 6. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PH: 15. 4% to $1042. 08.

08

Which pays a better dividend — PH or EMR?

All stocks in this comparison pay dividends.

Emerson Electric Co. (EMR) offers the highest yield at 1. 4%, versus 0. 7% for Parker-Hannifin Corporation (PH).

09

Is PH or EMR better for a retirement portfolio?

For long-horizon retirement investors, Parker-Hannifin Corporation (PH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

00), 0. 7% yield, +741. 1% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (PH: +741. 1%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between PH and EMR?

Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

PH

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Stocks Like

EMR

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform PH and EMR on the metrics below

Revenue Growth>
%
(PH: 10.6% · EMR: 2.9%)
Net Margin>
%
(PH: 16.6% · EMR: 13.3%)
P/E Ratio<
x
(PH: 33.3x · EMR: 36.6x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.